What is lobular carcinoma?
lobular carcinoma is a type of cancer that attacks breasts in the lobular area or the mammary glands of the breast. Lobular carcinoma is the second most common type of breast cancer. It creates approximately 10% of all breast cancer cases. There are two different types of lobular cancer. Normally it does not appear on the mammogram, but it seems to have better prognosis than other invasive breast cancer. The breast tumor tends to grow in the last part of the lobule. The tumor may feel like thickening in the upper outer part of the breast and can be found when a woman performs her own breast examination. Invasive lobular carcinoma often tests positive on estrogen or progesterone receptors and usually responds well to hormonal treatment. If the toning is caught in an early stage and treated, this type of cancer can eventually spread to female ovaries and uterus.
lobular carcinoma in situ (lcis) is a form of preinvasive breast cancer and is oftenconsidered as a precancerous breast condition. However, abnormal cells were discovered, but this particular diagnosis means that it was discovered before the breasts attacked cancer cells. During this phase, cancer cells have the ability to multiply, but have not moved to the lobule lining and other areas of the breast.
A woman who is diagnosed with lobular cancer in situ is exposed to a greater risk of developing invasive breast cancer later. Other risk factors for the development of breast cancer include the age of a woman, a family history of breast cancer, exposure to radiation and variable hormonal factors. You regularly check your breasts on any unusual lumps, nipple discharge or changes in the skin increase the chance of a woman to detect any type of cancer in the early stages.
accepting lobular cancer treatment in situ will depend on each individual situation. Treatment sometimes does not recommend the treatment of this condition because it is a precancerous condition. Instead, the doctor recommends the patient to be clinically checkedRegularly, so any early signs of invasive breast cancer can be captured and treated. The advantages of cancer treatment will be considered and compared with the risk of participating treatment. Treatment can be pursued to increase the chance of the patient to recover and prolong its survival.